Related Experiment Video
Updated: Apr 26, 2026

07:52
Fluorescence Molecular Tomography for In Vivo Imaging of Glioblastoma Xenografts
Published on: April 26, 2018
8.6K
[Intraoperative fluorescence diagnostics upon recurrent operations for brain gliomas]
Zhurnal Voprosy Neirokhirurgii Imeni N. N. Burdenko
|July 19, 2014
Summary
Fluorescent diagnosis using 5-aminolevulinic acid (5-ALA) aids in surgically identifying brain glioma boundaries. However, its accuracy in recurrent gliomas requires careful interpretation due to potential non-specific fluorescence.
Area of Science:
- Neurosurgery
- Oncology
- Medical Imaging
Context:
- 5-aminolevulinic acid (5-ALA) fluorescent diagnosis (FD) is established for primary brain tumors.
- Its application in recurrent gliomas remains less explored.
- Accurate intraoperative tumor delineation is critical for maximizing resection and improving patient outcomes.
Purpose:
- To evaluate the efficacy of 5-ALA FD combined with laser spectral analysis for recurrent glioma surgery.
- To assess the intraoperative demarcation capabilities of FD in this patient population.
Summary:
- 19 patients with recurrent Grade II-IV gliomas underwent surgery using 5-ALA FD and laser spectral analysis.
- Detectable fluorescence was observed in all cases, with quantitative analysis of protoporphyrin IX (PP IX) indices.
- Light scattering analysis showed an inverse correlation with fluorescence, providing complementary tissue information.
Impact:
- 5-ALA FD can assist in defining tumor resection margins for recurrent cerebral gliomas.
- High sensitivity necessitates critical evaluation in post-radiation cases due to potential non-specific PP IX accumulation.
- Light scattering analysis offers additional insights into surgical wound tissue characteristics.

